LL-37 Therapy
What is LL-37?
LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. It is a key component of the innate immune system and is produced by various cell types including neutrophils, macrophages, and epithelial cells. LL-37 has broad-spectrum antimicrobial activity against bacteria, viruses, and fungi, and also plays important roles in wound healing and immune modulation.
Benefits & Uses
Broad-spectrum antimicrobial activity (antibacterial, antiviral, antifungal), promotes wound healing, modulates immune response, may help with chronic infections and biofilm disruption, anti-inflammatory properties.
Potential Side Effects
Injection site reactions, possible mild flu-like symptoms. At high concentrations, may cause tissue irritation. Research peptide with limited large-scale human safety data.
Find LL-37 Providers Near You
Search our directory for providers offering LL-37 therapy.
Browse ProvidersFrequently Asked Questions
Broad-spectrum antimicrobial activity (antibacterial, antiviral, antifungal), promotes wound healing, modulates immune response, may help with chronic infections and biofilm disruption, anti-inflammatory properties.
LL-37 therapy typically costs between $150 and $400 per month, though prices vary by provider, location, and dosage.
LL-37 has an FDA status of "Research". It is currently used in research and clinical settings. Consult with a qualified provider about its regulatory status and appropriate use.
Injection site reactions, possible mild flu-like symptoms. At high concentrations, may cause tissue irritation. Research peptide with limited large-scale human safety data.
PeptideProbe lists 0 providers offering LL-37 therapy. Use our directory to search by location, filter by telehealth availability, and compare providers.
Related Peptides
Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.